Equitable Access Licensing: Difference between revisions
Jump to navigation
Jump to search
(Created page with ' =Description= Janet Hope: “Equitable Access” and “Neglected Disease Licensing” are twin elements of an open source-inspired proposal for improving access to essen...') |
GoodRollin (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
=Description= | =Description= | ||
| Line 17: | Line 16: | ||
[[Category:IP]] | [[Category:IP]] | ||
[[Category:Licensing]] | |||
Latest revision as of 00:08, 4 July 2010
Description
Janet Hope:
“Equitable Access” and “Neglected Disease Licensing” are twin elements of an open source-inspired proposal for improving access to essential medicines, put forward by Amy Kapczynski and colleagues at Yale University. These licensing models explicitly envisage universities as licensors but could be adopted, for example, by other researchers and institutions operating within the TDI framework described above. Equitable Access licensing aims to improve access to biomedical innovations in low-and middle-income countries. Neglected Disease licensing aims to facilitate research on orphan or neglected diseases." (http://opensourcebiotech.anu.edu.au/Open_Source_Biotechnology/Practice.html)